SCHEMBL24318007

SCHEMBL24318007

c1ccc(-c2nc(-c3cccc(-c4ccc5oc6cc7oc8ccccc8c7cc6c5c4)c3)nc(-c3cccc4c3sc3cc(-c5ccc(-c6nc(-c7ccc8c(c7)oc7cc9oc%10ccccc%10c9cc78)nc(-c7cccc8c7sc7ccccc78)n6)cc5)ccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 9/20 0.41
ALOX5 P09917 1/20 0.37
LIMK1 P53667 4/20 0.35
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
PLA2G10 O15496 1/20 0.34
PIK3CD O00329 2/20 0.33
PIK3CB P42338 2/20 0.33
BRD4 O60885 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
KCNH2 Q12809 1/20 0.32
BRDT Q58F21 1/20 0.32
LIMK2 P53671 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
PIM3 Q86V86 2/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25952183 0.96 PRKDC (0.40) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24318012 0.96 ALOX5 (0.40) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL21784867 0.95 PRKDC (0.41) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24318010 0.95 ALOX5 (0.40) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24318038 0.95 PRKDC (0.44) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24318008 0.95 ALOX5 (0.40) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264197 0.94 PRKDC (0.41) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24217295 0.94 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264255 0.94 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264112 0.94 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 PRKDC 2806/4885ALOX5 1698/4885LIMK1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.